Su‐Fang Lin

5.3k total citations · 2 hit papers
60 papers, 3.6k citations indexed

About

Su‐Fang Lin is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Su‐Fang Lin has authored 60 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 28 papers in Epidemiology and 15 papers in Infectious Diseases. Recurrent topics in Su‐Fang Lin's work include Viral-associated cancers and disorders (38 papers), Cytomegalovirus and herpesvirus research (26 papers) and Parvovirus B19 Infection Studies (14 papers). Su‐Fang Lin is often cited by papers focused on Viral-associated cancers and disorders (38 papers), Cytomegalovirus and herpesvirus research (26 papers) and Parvovirus B19 Infection Studies (14 papers). Su‐Fang Lin collaborates with scholars based in Taiwan, United States and Japan. Su‐Fang Lin's co-authors include Dan R. Robinson, Yi‐Mi Wu, Ren Sun, George Miller, Lyndle Gradoville, Yan Yuan, Fanxiu Zhu, Hsing-Jien Kung, Elizabeth Grogan and Katherine Staskus and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Su‐Fang Lin

60 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The protein tyrosine kinase family of the human genome

2000 830 citations Dan R. Robinson, Yi‐Mi Wu et al. Oncogene profile →
A viral gene that activates lytic cycle expression of Kaposi’s sarcoma-associated herpesvirus

1998 514 citations Ren Sun, Su‐Fang Lin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Su‐Fang Lin Taiwan	28	2.2k	1.8k	1.1k	480	466	60	3.6k
Vivian Ruvolo United States	36	1.6k 0.7×	729 0.4×	2.9k 2.7×	748 1.6×	285 0.6×	153	4.7k
Sibylle Mittnacht United Kingdom	33	3.2k 1.5×	789 0.5×	3.1k 3.0×	690 1.4×	190 0.4×	71	5.2k
Subburaj Ilangumaran Canada	35	1.1k 0.5×	475 0.3×	1.6k 1.5×	1.5k 3.1×	184 0.4×	101	3.6k
Katja Pokrovskaja Tamm Sweden	30	1.0k 0.5×	589 0.3×	1.3k 1.2×	606 1.3×	94 0.2×	62	2.4k
Yaël Mamane Canada	21	939 0.4×	502 0.3×	1.7k 1.6×	1.7k 3.5×	223 0.5×	27	3.5k
David Maag United States	27	1.3k 0.6×	514 0.3×	2.7k 2.6×	236 0.5×	482 1.0×	57	4.6k
Mary Ann Sells United States	26	863 0.4×	1.4k 0.8×	3.4k 3.2×	635 1.3×	381 0.8×	32	5.3k
Jürgen Müllberg Germany	31	2.0k 0.9×	698 0.4×	919 0.9×	2.5k 5.3×	137 0.3×	39	4.2k
Mario Rossi Italy	29	1.3k 0.6×	468 0.3×	2.1k 1.9×	288 0.6×	259 0.6×	63	3.2k
Thomas Chittenden United States	11	1.5k 0.7×	712 0.4×	1.8k 1.7×	525 1.1×	64 0.1×	25	3.4k

Countries citing papers authored by Su‐Fang Lin

Since Specialization

Citations

This map shows the geographic impact of Su‐Fang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐Fang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐Fang Lin more than expected).

Fields of papers citing papers by Su‐Fang Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su‐Fang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐Fang Lin. The network helps show where Su‐Fang Lin may publish in the future.

Co-authorship network of co-authors of Su‐Fang Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Su‐Fang Lin. A scholar is included among the top collaborators of Su‐Fang Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su‐Fang Lin. Su‐Fang Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Yulin, Shih‐Han Huang, Su‐Fang Lin, et al.. (2025). Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11a-dependent glycolytic reprogramming. Oncogenesis. 14(1). 6–6. 3 indexed citations

Chen, Wen‐Ling, Su‐Fang Lin, Ulrike Protzer, et al.. (2025). Differential regulation of calcium-NFAT signaling pathway by Akt isoforms: unraveling effector dynamics and exhaustion of cytotoxic T lymphocytes in tumor microenvironment. Journal for ImmunoTherapy of Cancer. 13(3). e009827–e009827. 2 indexed citations

Lien, Huang‐Chun, Hui‐Chieh Yu, Wen-Hsuan Yu, et al.. (2024). Characteristics and transcriptional regulators of spontaneous epithelial–mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinoma. Breast Cancer Research. 26(1). 130–130. 3 indexed citations

Chen, Mingyu, Su‐Fang Lin, Cheng–Yuan Kao, et al.. (2024). PTEN acts as a crucial inflammatory checkpoint controlling TLR9/IL-6 axis in B cells. iScience. 27(7). 110388–110388. 2 indexed citations

Lai, Ting‐Yu, et al.. (2023). The Way to Malignant Transformation: Can Epigenetic Alterations Be Used to Diagnose Early-Stage Head and Neck Cancer?. Biomedicines. 11(6). 1717–1717. 2 indexed citations

Liu, Yi‐Hong, Yulian Chen, Ting‐Yu Lai, et al.. (2021). Identification of Prognostic Biomarkers Originating From the Tumor Stroma of Betel Quid-Associated Oral Cancer Tissues. Frontiers in Oncology. 11. 769665–769665. 8 indexed citations

Cheng, Ann‐Joy, et al.. (2020). Discoidin Domain Receptor-1 (DDR1) is Involved in Angiolymphatic Invasion in Oral Cancer. Cancers. 12(4). 841–841. 23 indexed citations

Peng, Hsuan-Yu, Yuan-Ming Hsu, Jenn-Ren Hsiao, et al.. (2019). MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1. Journal of Experimental & Clinical Cancer Research. 38(1). 281–281. 63 indexed citations

Wu, Chung-Chun, Chih‐Yeu Fang, Hui‐Yu Hsu, et al.. (2016). Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes. Antiviral Research. 132. 99–110. 47 indexed citations

10.

Hillmer, Ansel T., Irina Esterlis, Jean‐Dominique Gallezot, et al.. (2016). Imaging of cerebral α4β2* nicotinic acetylcholine receptors with (−)-[18F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain. NeuroImage. 141. 71–80. 50 indexed citations

11.

Park, Richard, Ayman El‐Guindy, Lee Heston, et al.. (2014). Nuclear Translocation and Regulation of Intranuclear Distribution of Cytoplasmic Poly(A)-Binding Protein Are Distinct Processes Mediated by Two Epstein Barr Virus Proteins. PLoS ONE. 9(4). e92593–e92593. 15 indexed citations

12.

Huang, Sheng‐Yen, Chih‐Yeu Fang, Chung-Chun Wu, et al.. (2013). Reactive Oxygen Species Mediate Epstein-Barr Virus Reactivation by N-Methyl-N’-Nitro-N-Nitrosoguanidine. PLoS ONE. 8(12). e84919–e84919. 40 indexed citations

13.

Lee, Chung‐Pei, Jen‐Yang Chen, Su‐Fang Lin, et al.. (2012). Epstein-Barr Virus BGLF4 Kinase Retards Cellular S-Phase Progression and Induces Chromosomal Abnormality. PLoS ONE. 7(6). e39217–e39217. 52 indexed citations

14.

Wang, Pei‐Wen, Shu‐Yu Lin, I‐Lin Wu, et al.. (2012). Ser-634 and Ser-636 of Kaposi’s Sarcoma-Associated Herpesvirus RTA are Involved in Transactivation and are Potential Cdk9 Phosphorylation Sites. Frontiers in Microbiology. 3. 60–60. 14 indexed citations

15.

Chen, Yen‐Ju, et al.. (2011). Epstein–Barr Virus (EBV) Rta-Mediated EBV and Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivations in 293 Cells. PLoS ONE. 6(3). e17809–e17809. 15 indexed citations

16.

Brown, Helen, Peng Li, Josephine N. Harada, et al.. (2010). Gene Expression and Transcription Factor Profiling Reveal Inhibition of Transcription Factor cAMP-response Element-binding Protein by γ-Herpesvirus Replication and Transcription Activator. Journal of Biological Chemistry. 285(33). 25139–25153. 8 indexed citations

17.

Grogan, Elizabeth, et al.. (2000). Dihydrofolate Reductase from Kaposi's Sarcoma-Associated Herpesvirus. Virology. 268(1). 201–217. 14 indexed citations

18.

Robinson, Dan R., Yi‐Mi Wu, & Su‐Fang Lin. (2000). The protein tyrosine kinase family of the human genome. Oncogene. 19(49). 5548–5557. 830 indexed citations breakdown →

19.

Angeloni, Antonio, Lee Heston, Stefania Uccini, et al.. (1998). High Prevalence of Antibodies to Human Herpesvirus 8 in Relatives of Patients with Classic Kaposi's Sarcoma from Sardinia. The Journal of Infectious Diseases. 177(6). 1715–1718. 69 indexed citations

20.

Liu, Ming‐Tsan, et al.. (1998). Distinct Regions of EBV DNase Are Required for Nuclease and DNA Binding Activities. Virology. 242(1). 6–13. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact